HIMS: financial statements from SEC — TradeAlmanac

HIMS

Hims & Hers Health, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31 Mar 2026	30 Sept 2025	30 Jun 2025	31 Mar 2025	30 Sept 2024	30 Jun 2024
Revenue	608M	599M	545M	586M	402M	316M
Cost of revenue	211M	157M	129M	155M	84M	59M
Gross profit	397M	442M	416M	431M	318M	257M
Selling, general and administrative	110M	81M	67M	49M	45M	41M
Operating expenses	475M	430M	389M	373M	296M	246M
Operating income	−78M	12M	27M	58M	22M	11M
Pre-tax income	−102M	12M	33M	60M	24M	13M
Income tax	−9M	−4M	−10M	11M	−52M	127,000
Net income	−92M	16M	43M	49M	76M	13M
Earnings per share	−0.40	0.07	0.19	0.22	0.35	0.06
Earnings per share, diluted	−0.40	0.06	0.17	0.20	0.32	0.06
Weighted average shares	228M	226M	224M	222M	217M	215M
Weighted average shares, diluted	228M	249M	257M	247M	235M	235M

Balance sheet

Metric	31 Mar 2026	31 Dec 2025	30 Sept 2025	30 Jun 2025	31 Mar 2025	31 Dec 2024	30 Sept 2024	30 Jun 2024
Cash and equivalents	222M	229M	346M	1.12B	274M	221M	166M	129M
Receivables	150M	32M

Cash flow

Metric	31 Mar 2026	31 Mar 2025
Operating cash flow	89M	109M
Depreciation and amortisation	22M	8M
Share-based compensation	37M	25M
Investing cash flow	−15M	−33M
Share buybacks	—	0
Financing cash flow	−78M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator